Latest News
October 6, 2020
Immunexpress’ rapid test for sepsis launched in Europe on Biocartis’ Idylla platform
September 9, 2020
Belgian scale-up Oncomfort raises €10 million in Series A funding co-led by Debiopharm and Crédit Mutuel Innovation to further develop…
July 7, 2020
Nucleai Secured $6.5m Series-A Initial Closing Led by Debiopharm to Advance Ai-Powered Precision Oncology Platform
July 7, 2020
Debiopharm invests in NucleAI– using AI to develop digital pathology biomarkers
June 17, 2020
Immunexpress awarded funding to develop their COVID-19 patient triage test SeptiCyte® RAPID
May 26, 2020
Acquisition of Debiopharm’s Investment Portfolio Company Kaiku Health Broadens Patient Access to Digital Oncology Intervention
May 20, 2020
BC Platforms Honored by Microsoft for their Efforts to “Reimagine Health” with Kaiser Permanente